KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Other Accumulated Expenses (2020 - 2025)

Historic Other Accumulated Expenses for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $1.5 billion.

  • Oscar Health's Other Accumulated Expenses rose 727.15% to $1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 727.15%. This contributed to the annual value of $1.5 billion for FY2025, which is 727.15% up from last year.
  • Per Oscar Health's latest filing, its Other Accumulated Expenses stood at $1.5 billion for Q4 2025, which was up 727.15% from $1.6 billion recorded in Q3 2025.
  • Oscar Health's 5-year Other Accumulated Expenses high stood at $1.6 billion for Q3 2025, and its period low was $358.1 million during Q1 2021.
  • In the last 5 years, Oscar Health's Other Accumulated Expenses had a median value of $960.0 million in 2023 and averaged $1.0 billion.
  • In the last 5 years, Oscar Health's Other Accumulated Expenses surged by 11617.47% in 2022 and then plummeted by 856.74% in 2023.
  • Oscar Health's Other Accumulated Expenses (Quarter) stood at $513.6 million in 2021, then skyrocketed by 82.59% to $937.7 million in 2022, then grew by 3.01% to $966.0 million in 2023, then soared by 40.45% to $1.4 billion in 2024, then grew by 7.27% to $1.5 billion in 2025.
  • Its Other Accumulated Expenses was $1.5 billion in Q4 2025, compared to $1.6 billion in Q3 2025 and $1.6 billion in Q2 2025.